Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Aug;12(4):207-9.
doi: 10.1007/s11906-010-0124-4.

ESCAPE: From hypertension to renal failure

Helmy M Siragy  1
Affiliations
Comment

ESCAPE: From hypertension to renal failure

Helmy M Siragy. Curr Hypertens Rep. 2010 Aug.

Abstract

ESCAPE Trial Group, Wühl E, Trivelli A, et al.: Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639–1650.

PubMed Disclaimer

Conflict of interest statement

Disclosure No potential conflict of interest relevant to this article was reported.

Comment on

  • Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group; Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F. ESCAPE Trial Group, et al. N Engl J Med. 2009 Oct 22;361(17):1639-50. doi: 10.1056/NEJMoa0902066. N Engl J Med. 2009. PMID: 19846849 Clinical Trial.

References

    1. Chobanian A, Bakris G, Black H, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252. - PubMed
    1. Staples A, Wong C. Risk factors for progression of chronic kidney disease. Curr Opin Pediatr. 2010;22:161–169. - PMC - PubMed
    1. Bakris GL. Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol. 2008;3(Suppl 1):S3–S10. - PMC - PubMed
    1. Parving HH, Lehnert H, Bröchner-Mortensen J, et al. Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–878. - PubMed
    1. Jafer TH, Schmid CH, Landa M. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87. - PubMed

LinkOut - more resources